Ureteral Diseases clinical trials at UCLA

1 research study open to eligible people

Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
open to eligible people ages 21-80
A prospective, multi-center, non-randomized trial to demonstrate safety and device performance of the ADVA-Tec Uriprene® Degradable Temporary Ureteral Stent.
Los Angeles, California and other locations

Last updated: August 30, 2024